These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15640789)

  • 1. Design and manufacture of monoclonal antibodies for radioimmunotherapy.
    Hale G; Berrie E; Bird P
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered single chain antibody fragments for radioimmunotherapy.
    Huhalov A; Chester KA
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):279-88. PubMed ID: 15640791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manufacture of recombinant polyclonal antibodies.
    Rasmussen SK; Rasmussen LK; Weilguny D; Tolstrup AB
    Biotechnol Lett; 2007 Jun; 29(6):845-52. PubMed ID: 17310321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preparation of radiolabeled monoclonal antibodies for human use.
    Tran L; Beijnen JH; Huitema AD
    Hum Antibodies; 2009; 18(4):145-56. PubMed ID: 19996529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in antibody manufacturing using mammalian cells.
    Morrow KJ
    Biotechnol Annu Rev; 2007; 13():95-113. PubMed ID: 17875475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated radiolabelling of monoclonal antibodies with the Modular Lab system.
    Ellison D; Kaufman J; Mather SJ
    Nucl Med Commun; 2010 Feb; 31(2):173-7. PubMed ID: 19952855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tunable antibodies.
    Weiner LM; Carter P
    Nat Biotechnol; 2005 May; 23(5):556-7. PubMed ID: 15877072
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
    Reilly RM
    J Nucl Med; 2006 Feb; 47(2):196-9. PubMed ID: 16455623
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody production.
    Birch JR; Racher AJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):671-85. PubMed ID: 16822577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of humanized antibodies as cancer therapeutics.
    Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
    Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?
    Dinnis DM; James DC
    Biotechnol Bioeng; 2005 Jul; 91(2):180-9. PubMed ID: 15880827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of humanized IgGs in glycoengineered Pichia pastoris.
    Li H; Sethuraman N; Stadheim TA; Zha D; Prinz B; Ballew N; Bobrowicz P; Choi BK; Cook WJ; Cukan M; Houston-Cummings NR; Davidson R; Gong B; Hamilton SR; Hoopes JP; Jiang Y; Kim N; Mansfield R; Nett JH; Rios S; Strawbridge R; Wildt S; Gerngross TU
    Nat Biotechnol; 2006 Feb; 24(2):210-5. PubMed ID: 16429149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines to cell engineering for monoclonal antibody production.
    Rita Costa A; Elisa Rodrigues M; Henriques M; Azeredo J; Oliveira R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):127-38. PubMed ID: 19853660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotype selection in antibody engineering.
    Salfeld JG
    Nat Biotechnol; 2007 Dec; 25(12):1369-72. PubMed ID: 18066027
    [No Abstract]   [Full Text] [Related]  

  • 18. Site-specific 32P-labeling of cytokines, monoclonal antibodies, and other protein substrates for quantitative assays and therapeutic application.
    Clark WA; Izotova L; Philipova D; Wu W; Lin L; Pestka S
    Biotechniques; 2002 Oct; Suppl():76-8, 80-7. PubMed ID: 12395930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing mammalian cell culture engineering using genome-scale technologies.
    Griffin TJ; Seth G; Xie H; Bandhakavi S; Hu WS
    Trends Biotechnol; 2007 Sep; 25(9):401-8. PubMed ID: 17681628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of advanced technologies in commercial monoclonal antibody production.
    Zhou JX; Tressel T; Yang X; Seewoester T
    Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.